← k3vl4r
Log inGet started →

PDSB (PDS Biotechnology Corp) Price Forecast

AI-generated price forecast for PDS Biotechnology Corp (PDSB) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of October 2026: K3vl4r's calibrated AI forecast currently reads PDSB as 1/1 bullish across its horizons (1 of 1 timeframes pointing up), with a last price of 1.05. Measured over its last 458 resolved daily forecasts (45-day window), the model's direction call on PDSB was correct 83% of the time. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

1.05

AI outlook

1/1 bullish

Timeframes up

1 / 1

Measured daily accuracy

83%

458 resolved forecasts · 45d window

Share𝕏PostTelegram

PDSB forecast by horizon

HorizonDirectionCalibrated move (end of horizon)
1-hour——
4-hour——
Daily~4 weeks out▲ Up+7.70%
WeeklyNot enough track record yet—

Calibrated: each horizon's forecast is weighted by how often the model has called PDSB's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.

Latest PDSB news

From the market-news feed the forecasts are read against.

  • PDS Biotech to Host Key Opinion Leader Event on PDS0301 for the Treatment of Advanced Colorectal Cancer with Liver Metastases · Yahoo · Oct 6
  • PDS Biotech Announces Publication of VERSATILE-002 Phase 2 Clinical Trial Results of PDS0101 with pembrolizumab in HPV16-Positive Recurrent and/or Metastatic (R/M) Head and Neck Cancer in JAMA Oncology · Yahoo · Sep 22
  • PDS Biotechnology Announces Publication Of Results From Phase 2 Trial Evaluating PDS0101, HPV16-Targeted Immunotherapy, In Combination With Pembrolizumab In JAMA Oncology, Peer Reviewed Journal Of American Medical Association · Benzinga · Sep 22
  • PDS Biotechnology (PDSB) Stock Fair Value Moves Lower After Analyst Cuts And Financing Scrutiny · Simply Wall St. · Sep 18
  • 12 Health Care Stocks Moving In Wednesday's Intraday Session · Benzinga · Sep 16

🔒

See the full PDSB forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

PDSB forecast — frequently asked

Will PDSB go up?

K3vl4r's calibrated AI forecast currently reads PDSB as 1/1 bullish — 1 of 1 forecast horizons point up, so the overall read is leaning to the upside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

How accurate is the PDSB AI forecast?

Measured over its last 458 resolved daily forecasts (45-day window), the model's direction call on PDSB was correct 83% of the time. Accuracy is recomputed continuously against resolved outcomes and varies by symbol, horizon and market regime; past accuracy does not guarantee future results. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the PDSB price prediction for 2026?

K3vl4r's model projects PDSB toward $1.10 over the next ~4 weeks, a +7.7% move from $1.02. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

SGRYOTLKINMBCGEMMMSIEBSINSMADCTJANXABUSMLSSSEERARQTTARS

Will PDSB reach…?

Will PDSB reach $2.00?Will PDSB reach $3.00?Will PDSB reach $5.00?

Or see the full PDSB price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare PDSB

PDSB vs SGRYPDSB vs OTLKPDSB vs INMBPDSB vs CGEMPDSB vs MMSIPDSB vs EBS

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rTop PicksTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.